Coronary artery outcomes among children with Kawasaki disease in the United States and Japan

详细信息    查看全文

• 作者：Shohei Ogata ; Adriana H. Tremoulet ; Yuichiro Sato ; Kayla Ueda ; Chisato Shimizu ; Xiaoying Sun ; Sonia Jain ; Laura Silverstein ; Annette L. Baker ; Noboru Tanaka ; Yoshihito Ogihara ; Satoshi Ikehara ; Shinichi Takatsuki ; Naoko Sakamoto ; Tohru Kobayashi ; Shigeto Fuse ; Tomoyo Matsubara ; Masahiro Ishii ; Tsutomu Saji ; Jane W. Newburger ; et al.
• 关键词：Kawasaki disease ; Coronary artery aneurysm ; Z score ; Vasculitis ; Echocardiography
• 刊名：International Journal of Cardiology
• 出版年：2013
• 出版时间：9 October, 2013
• 年：2013
• 卷：168
• 期：4
• 页码：3825-3828
• 全文大小：316 K

文摘

Objective

It has been claimed that the aneurysm rate for Kawasaki disease (KD) patients in Japan is lower than in the U.S. However it has been difficult to compare coronary artery (CA) outcomes between the two countries because of different definitions for CA abnormalities. Therefore, we compared CA internal diameters between Japanese and U.S. KD patients using standard definitions and methods.

Study design

We retrospectively reviewed CA outcomes in 1082 KD patients from 2 centers in the U.S. and 3 centers in Japan and compared Z-max scores (maximum internal diameter for the left anterior descending or right coronary artery expressed as standard deviation units from the mean (Z-score) normalized for body surface area) obtained within 12 weeks after onset and calculated using two different regression equations from Canada (Dallaire) and Japan (Fuse). We defined a Z-max of < 2.5 as normal and a Z-max of ¡Ý 10 as giant aneurysm.

Result

The median Z-max for the U.S. and Japanese subjects was 1.9 and 2.3 SD units, respectively (p < 0.001). There was no significant difference in rates of patients with Z-max ¡Ý 5.0 between the countries. In a multivariable model adjusting for age, sex, and treatment response, being Japanese was still associated with a higher Z-max score.

Conclusion

Previously reported differences in aneurysm rates between Japan and the U.S. likely resulted from use of different definitions and nomenclature. Adoption of Z-scores as a standard for reporting CA internal diameters will allow meaningful comparisons among different countries and will facilitate international, collaborative clinical trials.